D-Index & Metrics Best Publications
Research.com 2022 Best Female Scientist Award Badge

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Best female scientists D-index 100 Citations 30,616 462 World Ranking 906 National Ranking 570
Medicine D-index 96 Citations 28,816 439 World Ranking 5953 National Ranking 3284

Research.com Recognitions

Awards & Achievements

2022 - Research.com Best Female Scientist Award

2009 - Distinguished Scientist Award, American Heart Association

Overview

What is she best known for?

The fields of study she is best known for:

  • Gene
  • Enzyme
  • Internal medicine

Evangelia G. Kranias mainly investigates Internal medicine, Phospholamban, Endocrinology, Contractility and Phosphorylation. Evangelia G. Kranias studied Internal medicine and Cardiology that intersect with Cause of death and Function. Her Phospholamban research is under the purview of Endoplasmic reticulum.

Evangelia G. Kranias has included themes like Cardiac function curve, Calcium metabolism and Troponin I in her Endocrinology study. Her research in Contractility intersects with topics in Inflammation, Pressure overload, Diastole, Sarcolipin and In vivo. Evangelia G. Kranias has researched Phosphorylation in several fields, including Molecular biology and Apoptosis.

Her most cited work include:

  • Phospholamban: a crucial regulator of cardiac contractility (815 citations)
  • Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulation. (620 citations)
  • PKC-alpha regulates cardiac contractility and propensity toward heart failure. (537 citations)

What are the main themes of her work throughout her whole career to date?

Her main research concerns Internal medicine, Phospholamban, Endocrinology, Endoplasmic reticulum and Contractility. As part of the same scientific family, Evangelia G. Kranias usually focuses on Internal medicine, concentrating on Cardiology and intersecting with Diastole. Her Phospholamban study incorporates themes from SERCA, Ca2+/calmodulin-dependent protein kinase and Cardiac muscle.

Her Endocrinology research is multidisciplinary, incorporating perspectives in Ryanodine receptor, Dilated cardiomyopathy and Calcium-binding protein. Her studies deal with areas such as Biophysics and ATPase, Calcium ATPase as well as Endoplasmic reticulum. Her studies in Contractility integrate themes in fields like Genetically modified mouse, Contraction and In vivo.

She most often published in these fields:

  • Internal medicine (70.16%)
  • Phospholamban (63.04%)
  • Endocrinology (61.07%)

What were the highlights of her more recent work (between 2012-2021)?

  • Internal medicine (70.16%)
  • Phospholamban (63.04%)
  • Endocrinology (61.07%)

In recent papers she was focusing on the following fields of study:

Internal medicine, Phospholamban, Endocrinology, Heart failure and Ryanodine receptor are her primary areas of study. Her Internal medicine research includes elements of Ca2+/calmodulin-dependent protein kinase and Cardiology. Evangelia G. Kranias is doing genetic studies as part of her Endoplasmic reticulum and Phosphorylation and Phospholamban investigations.

Evangelia G. Kranias is interested in Myocyte, which is a field of Endocrinology. Her biological study spans a wide range of topics, including Muscle hypertrophy and Inotrope. Evangelia G. Kranias interconnects Stimulation and Ventricular remodeling in the investigation of issues within Contractility.

Between 2012 and 2021, her most popular works were:

  • Correction of human phospholamban R14del mutation associated with cardiomyopathy using targeted nucleases and combination therapy (114 citations)
  • Correction of human phospholamban R14del mutation associated with cardiomyopathy using targeted nucleases and combination therapy (114 citations)
  • Phospholamban interactome in cardiac contractility and survival: A new vision of an old friend. (64 citations)

In her most recent research, the most cited papers focused on:

  • Gene
  • Enzyme
  • Internal medicine

Evangelia G. Kranias spends much of her time researching Internal medicine, Phospholamban, Contractility, Endocrinology and Heart failure. The study incorporates disciplines such as Function and Cardiology in addition to Internal medicine. Her Phospholamban study is concerned with the larger field of Endoplasmic reticulum.

Her Endoplasmic reticulum research incorporates themes from Protein phosphatase 1, Dephosphorylation, Downregulation and upregulation and Post-transcriptional regulation. Her work deals with themes such as Calcium-binding protein, Calcium and Phosphorylation, which intersect with Endocrinology. Evangelia G. Kranias has included themes like Ventricular pressure and Myocardial infarction in her Heart failure study.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Phospholamban: a crucial regulator of cardiac contractility

David H. MacLennan;Evangelia G. Kranias.
Nature Reviews Molecular Cell Biology (2003)

1155 Citations

Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulation.

Wusheng Luo;Ingrid L. Grupp;Judy Harrer;Sathivel Ponniah.
Circulation Research (1994)

961 Citations

Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban.

Joachim P. Schmitt;Mitsuhiro Kamisago;Mitsuhiro Kamisago;Michio Asahi;Guo Hua Li.
Science (2003)

705 Citations

PKC-alpha regulates cardiac contractility and propensity toward heart failure.

Julian C Braz;Kimberly Gregory;Anand Pathak;Wen Zhao.
Nature Medicine (2004)

703 Citations

Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy.

Susumu Minamisawa;Masahiko Hoshijima;Guoxiang Chu;Christopher A Ward.
Cell (1999)

607 Citations

Modulation of Cardiac Contractility by the Phopholamban/SERCA2a Regulatome

Evangelia G. Kranias;Roger J. Hajjar.
Circulation Research (2012)

481 Citations

Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human

Kobra Haghighi;Fotis Kolokathis;Luke Pater;Roy A. Lynch.
Journal of Clinical Investigation (2003)

477 Citations

Fibroblast growth factor 2 control of vascular tone.

Ming Zhou;Roy L. Sutliff;Richard J. Paul;John N. Lorenz.
Nature Medicine (1998)

461 Citations

The effect of troponin I phosphorylation on the Ca2+-binding properties of the Ca2+-regulatory site of bovine cardiac troponin.

S P Robertson;J D Johnson;M J Holroyde;E G Kranias.
Journal of Biological Chemistry (1982)

457 Citations

Phospholamban: A Prominent Regulator of Myocardial Contractility

Kimberly L. Koss;Evangelia G. Kranias.
Circulation Research (1996)

426 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Evangelia G. Kranias

Roger J. Hajjar

Roger J. Hajjar

Icahn School of Medicine at Mount Sinai

Publications: 132

Donald M. Bers

Donald M. Bers

University of California, Davis

Publications: 122

Jeffery D. Molkentin

Jeffery D. Molkentin

Cincinnati Children's Hospital Medical Center

Publications: 77

R. John Solaro

R. John Solaro

University of Illinois at Chicago

Publications: 77

David D. Thomas

David D. Thomas

University of Minnesota

Publications: 63

Larry R. Jones

Larry R. Jones

Indiana University

Publications: 62

Kenneth R. Chien

Kenneth R. Chien

Karolinska Institute

Publications: 53

Gianluigi Veglia

Gianluigi Veglia

University of Minnesota

Publications: 51

Mark E. Anderson

Mark E. Anderson

Johns Hopkins University

Publications: 49

John N. Lorenz

John N. Lorenz

University of Cincinnati Medical Center

Publications: 48

Walter J. Koch

Walter J. Koch

Temple University

Publications: 48

Thomas Eschenhagen

Thomas Eschenhagen

Universität Hamburg

Publications: 44

David A. Kass

David A. Kass

Johns Hopkins University School of Medicine

Publications: 44

Edward G. Lakatta

Edward G. Lakatta

National Institutes of Health

Publications: 44

David H. MacLennan

David H. MacLennan

University of Toronto

Publications: 43

Naranjan S. Dhalla

Naranjan S. Dhalla

University of Manitoba

Publications: 43

Trending Scientists

Seoki Lee

Seoki Lee

Pennsylvania State University

Hossein Moayedi

Hossein Moayedi

Duy Tan University

Garry R. Cutting

Garry R. Cutting

Johns Hopkins University School of Medicine

Brian J. Shuter

Brian J. Shuter

University of Toronto

Anthony P. O'Grady

Anthony P. O'Grady

Illinois Tool Works (United States)

László Bögre

László Bögre

Royal Holloway University of London

Thaddeus S. Stappenbeck

Thaddeus S. Stappenbeck

Washington University in St. Louis

Ian Beveridge

Ian Beveridge

University of Melbourne

Lawrence M. Hanks

Lawrence M. Hanks

University of Illinois at Urbana-Champaign

Beatriz Guerra

Beatriz Guerra

European Food Safety Authority

Rainer Thomas

Rainer Thomas

University of Potsdam

Allan H. Wilson

Allan H. Wilson

University of the Witwatersrand

Mihalis Vrekoussis

Mihalis Vrekoussis

University of Bremen

Carol L. Krumhansl

Carol L. Krumhansl

Cornell University

Giuseppe Biondi-Zoccai

Giuseppe Biondi-Zoccai

Sapienza University of Rome

Constance D. Lehman

Constance D. Lehman

Harvard University

Something went wrong. Please try again later.